Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B

Blood

Volumn 105, Issue 10, 2005, Pages 3910-3917

  Sohn, Richard H ^b   Deming, Clayton B ^b   Johns, David C ^b   Champion, Hunter C ^b   Bian, Ce ^b   Gardner, Kevin ^b   Rade, Jeffrey J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTICOAGULANT AGENT; CYTOKINE; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C; THROMBOMODULIN; TRANSCRIPTION FACTOR ETS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; LUNG INJURY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOSIS; TM GENE; WESTERN BLOTTING;

EID: 18544384252     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-0928     Document Type: Article

References (57)

1. Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1:1343-1348.
2. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb Vasc Biol. 1992;12:135-145.
3. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408-416.
4. Van SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR. Low levels of protein C are associated with poor outcome in severe sepsis. Chest. 2001;120:915-922.
5. Bernard GR, Vincent J-L, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
6. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987;79:124-130.
7. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986;163:740-745.
8. Nawroth PP, Handley DA, Esmon CT, Stem DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986;83:3460-3464.
9. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol. 1988;8:5588-5592.
10. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomoduiin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood. 1991;77:542-550.
11. Yu K, Moriaka H, Fritze LMS, et al. Transcriptional regulation of the thrombomodulin gene. J Biol Chem. 1992;267:23237-23247.
12. Tazawa R, Hirosawa S, Suzuki K, Hirokawa K, Aoki N. Functional characterization of the 5′-regulatory region of the human thrombomodulin gene. J Biochem. 1993;113:600-606.
13. von der Ahe D, Nischan C, Kunz C, et al. Ets transcription factor binding site is required for positive and TNFa-induced negative promoter regulation. Nucleic Acid Res. 1993;21:5636-5643.
14. Rothwarf DM, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE. 1999;1999:RE1.
15. Baeuerle PA. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell. 1998;95:729-731.
16. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991;174:1517-1526.
17. Moll T, Czyz M, Holzmuller H, et al. Regulation of the tissue factor promoter in endothelial cells: binding of NF-kB, AP-1 and Sp-1-like transcription factors. J Biol Chem. 1995;270:3849-3957.
18. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:612-621.
19. Hamaguchi E, Takamura T, Shimizu A, Nagai Y. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB- dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther, 2003;307:987-994.
20. Reuning U, Guerrini L, Nishiguchi T, et al. Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells. Eur J Biochem. 1999;259:143-148.
21. Brockman JA, Scherer J, McKinsey TA, et al. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol. 1995;15:2809-2818.
22. Hardy S, Kitamura M, Harris-Stansil T, Dal Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997;71:1842-1849.
23. Fallaux FJ, Kranenburg O, Cramer SJ, et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther. 1996;7:215-222.
24. Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR, Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol. 2000;74:354-362.
25. Wu E, Fernandez J, Fleck SK, et al. A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. Virology. 2001;279:78-89.
26. Renard P, Ernest I, Houbion A, et al. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acid Res. 2001;29: E21-E26.
27. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limited numbers of mammalian cells. Nucleic Acid Res. 1991;19:2499.
28. Chaudhry S, Freebern WJ, Smith JL, et al. Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene. J Immunol. 2002;169:6767-6778.
29. Hehner SP, Heinrich M, Bork PM, et al. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem. 1998;273:1288-1297.
30. Garda-Pineres AJ, Castro V, Mora G, et al. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem. 2001;276:39713-30720.
31. Rabinovici R, Feuerstein G, Abdullah F, et al. Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury. Circ Res. 1996;78:329-336.
32. Li Y-P, Stashenko P. Characterization of a tumor necrosis factor-responsive element which down-regulates the human osteocalcin gene. Mol Cell Biol. 1993;13:3714-3721.
33. Kouba DJ, Chung KY, Nishiyama T, et al. Nuclear factor-κB mediates TNF-α inhibitory effect on α2(1) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol. 1999;162:4226-4234.
34. Gires O, Kieu C, Fix P, et al. Tumor necrosis factor α negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. Cancer. 2001;92:620-628.
35. Dittman WA, Nelson SC, Greer PK, et al. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene. J Biol Chem. 1994;269:16925-16932.
36. Sementchenko VI, Watson DK. Els target genes: past, present and future. Oncogene. 2000;19:6533-6548.
37. Jayaramann G, Srinivas R, Duggan C, et al. p300/cAMP-response element-binding protein interactions with Ets-1 and Ets-2 in the transcriptional activation of the human stromolysin promoter. J Biol Chem. 1999;274:17342- 17352.
38. Sheppard KA, Rose DW, Haque ZK, et al. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol. 1999;19:6367-6378.
39. Ravi R, Mookerjee B, van Hensbergen Y, et al. p53-mediated repression of nuclear factor-κB RelA via the transcriptional integrator p300. Cancer Res. 1998;58:4531-4536.
40. Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Jackman RW. Heat shock of vascular endothelial cells induces an up-regulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. J Biol Chem. 1994;269:22804-22810.
41. Wong HR, Ryan M, Wispe JR. Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells. J Clin Invest. 1997;99:2423-2428.
42. Wong HR, Ryan MA, Menendez IY, Wispe JR. Heat shock activates the I-kappaBalpha promoter and increases I-kappaBalpha mRNA expression. Cell Stress Chaperones. 1999;4:1-7.
43. Iber H, Chen Q, Cheng P-Y, Morgan ET. Suppression of CYP2C11 gene transcription by interleukin-1 B binding at the transcriptional start site. Arch Biochem Biophys. 2000;377:187-194.
44. Vo N, Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem. 2001;276:13505-13508.
45. Chan HM, La Thangue NB. p300/CPB proteins: HATs for transcriptional bridges and scaffolds. J Cell Science. 2001;114:2963-2973.
46. Speir E, Yu Z-X, Takeda K, Ferrans VJ, Canon RO. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-κB in human coronary smooth muscle cells. Circ Res. 2000;87:1006-1011.
47. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood. 1992;80:2556-2562.
48. Koga S, Morris S, Ogawa S, et al. TNF modulates endothelial properties by decreasing cAMP. Am J Physiol. 1995;268:C1104-C1113.
49. Kavurma MM, Bobryshev Y, Khachigian LM. Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1. J Biol Chem. 2002;277:36244-36252.
50. Bush TE, St Coeur M, Resendes KK, Rosmarin AG. GA-binding protein (GABP) and Sp1 are required, along with retinoid receptors, to mediate retinoic acid responsiveness of CD18 (β2 leukocyte integrin): a novel mechanism of transcriptional regulation in myeloid cells. Blood. 2002;101:311-317.
51. Tsai EY, Falvo JV, Tsytsykova AV, et al. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol. 2000;20:6084-6094.
52. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188:143-160.
53. Ollivier V, Parry GC, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem. 1996;271:20828-20835.
54. Parry GCN, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kB-mediated transcription. J Immunol. 1997;159:5450-5456.
55. Niforas P, Chu MD, Bird P. A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. Gene. 1996;176:139-147.
56. Hansen SK, Nerlov C, Zabel U, et al. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J. 1992;11:205-213.
57. Edelberg JM, Christie PD, Rosenberg RD. Regulation of vascular bed-specific prothrombotic potential. Circ Res. 2001;89:117-124.